Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modelling olanzapine-induced weight gain in rats
Esther M. van der Zwaal, Sanna K. Janhunen, Susanne E. la Fleur, et al.
The International Journal of Neuropsychopharmacology (2013) Vol. 17, Iss. 01, pp. 169-186
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects
Spyridon Siafis, Dimitrios Tzachanis, Myrto Samara, et al.
Current Neuropharmacology (2017) Vol. 16, Iss. 8, pp. 1210-1223
Open Access | Times Cited: 128
Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota
Amy Kao, Sonia Spitzer, Daniel C. Anthony, et al.
Translational Psychiatry (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 111
Reactivation of Early-Life Stress-Sensitive Neuronal Ensembles Contributes to Lifelong Stress Hypersensitivity
Julie‐Anne Balouek, Christabel Mclain, Adelaide R. Minerva, et al.
Journal of Neuroscience (2023) Vol. 43, Iss. 34, pp. 5996-6009
Open Access | Times Cited: 24
The effect of olanzapine on spatial memory impairment, depressive-like behavior, pain perception, and BDNF and synaptophysin expression following childhood chronic unpredictable mild stress in adult male and female rats
Zahra Farahani, Salar Vaseghi, Elham Rajabbeigi, et al.
Behavioural Brain Research (2024) Vol. 468, pp. 115039-115039
Closed Access | Times Cited: 11
Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes
Jiezhong Chen, Xu‐Feng Huang, Renfu Shao, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 76
Intrinsic and Antipsychotic Drug-Induced Metabolic Dysfunction in Schizophrenia
Zachary Freyberg, Despoina Aslanoglou, Ripal Shah, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 66
The impact of common pharmaceutical excipients on the gut microbiota
Santhni Subramaniam, Srinivas Kamath, Amin Ariaee, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 10, pp. 1297-1314
Open Access | Times Cited: 20
The common pathophysiology underlying the metabolic syndrome, schizophrenia and depression. A review
Jana Kučerová, Zuzana Babinská, Kateřina Horská, et al.
Biomedical Papers (2014) Vol. 159, Iss. 2, pp. 208-214
Open Access | Times Cited: 54
Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in rats
Xuemei Liu, Zhixiang Wu, Jiamei Lian, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 45
Betahistine co-treatment ameliorates dyslipidemia induced by chronic olanzapine treatment in rats through modulation of hepatic AMPKα-SREBP-1 and PPARα-dependent pathways
Xuemei Liu, Jiamei Lian, Changhua Hu, et al.
Pharmacological Research (2015) Vol. 100, pp. 36-46
Closed Access | Times Cited: 42
Metabolic side effects induced by olanzapine treatment are neutralized by CB1 receptor antagonist compounds co-administration in female rats
Paolo Lazzari, Valeria Serra, S. Marcello, et al.
European Neuropsychopharmacology (2017) Vol. 27, Iss. 7, pp. 667-678
Closed Access | Times Cited: 41
Olanzapine-depot administration induces time-dependent changes in adipose tissue endocrine function in rats
Kateřina Horská, Jana Kučerová, Zuzana Babinská, et al.
Psychoneuroendocrinology (2016) Vol. 73, pp. 177-185
Closed Access | Times Cited: 32
Longitudinal Gut Microbiota Dysbiosis Underlies Olanzapine-Induced Weight Gain
豊田 隆謙, Xiaoyan He, Y. Liu, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 9
Samidorphan mitigates olanzapine-induced weight gain and metabolic dysfunction in rats and non-human primates
Jacobi I. Cunningham, David J. Eyerman, Mark S. Todtenkopf, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 10, pp. 1303-1316
Open Access | Times Cited: 27
Prebiotic reduction of brain histone deacetylase (HDAC) activity and olanzapine-mediated weight gain in rats, are acetate independent
Amy Kao, Ka Wai Chan, Daniel C. Anthony, et al.
Neuropharmacology (2019) Vol. 150, pp. 184-191
Open Access | Times Cited: 25
Simvastatin improves olanzapine-induced dyslipidemia in rats through inhibiting hepatic mTOR signaling pathway
Xuemei Liu, Xiaomin Zhao, Chao Deng, et al.
Acta Pharmacologica Sinica (2019) Vol. 40, Iss. 8, pp. 1049-1057
Open Access | Times Cited: 25
Prevention of the adverse effects of olanzapine on lipid metabolism with the antiepileptic zonisamide
Aneta Stefanidis, Matthew J. Watt, Michael A. Cowley, et al.
Neuropharmacology (2017) Vol. 123, pp. 55-66
Closed Access | Times Cited: 13
Regulation of obesity-associated metabolic disturbance by the antipsychotic drug olanzapine: Role of the autophagy-lysosome pathway
Xueli Zhang, Yi Zhao, Yamin Liu, et al.
Biochemical Pharmacology (2018) Vol. 158, pp. 114-125
Closed Access | Times Cited: 11
Olanzapine exposure diminishes perfusion and decreases volume of sensorimotor cortex in rats
Eva Dražanová, Lucie Krátká, Naděžda Vaškovicová, et al.
Pharmacological Reports (2019) Vol. 71, Iss. 5, pp. 839-847
Closed Access | Times Cited: 10
The Case for Clinical Trials with Novel GABAergic Drugs in Diabetes Mellitus and Obesity
F. Antoni
Life (2022) Vol. 12, Iss. 2, pp. 322-322
Open Access | Times Cited: 6
Exercise intervention for preventing risperidone-induced dyslipidemia and gluco-metabolic disorders in female juvenile rats
Emma Sylvester, Weijie Yi, Mei Han, et al.
Pharmacology Biochemistry and Behavior (2020) Vol. 199, pp. 173064-173064
Closed Access | Times Cited: 8
Longdan Xiegan Tang attenuates liver injury and hepatic insulin resistance by regulating the angiotensin-converting enzyme 2/Ang (1–7)/Mas axis-mediated anti-inflammatory pathway in rats
Chengliang Wang, Liying Ren, Shankang Chen, et al.
Journal of Ethnopharmacology (2021) Vol. 274, pp. 114072-114072
Closed Access | Times Cited: 8
Neural changes induced by antipsychotic administration in adolescence: A review of studies in laboratory rodents
Aung Aung Kywe Moe, James G. Scott, Thomas H.J. Burne, et al.
Journal of Psychopharmacology (2016) Vol. 30, Iss. 8, pp. 771-794
Closed Access | Times Cited: 7
Cevimeline co-treatment attenuates olanzapine-induced metabolic disorders via modulating hepatic M3 muscarinic receptor: AMPKα signalling pathway in female rats
Mei Han, Jiamei Lian, Yueqing Su, et al.
Journal of Psychopharmacology (2021) Vol. 36, Iss. 2, pp. 202-213
Closed Access | Times Cited: 7
Metabolic and endocrinal effects of N-desmethyl-olanzapine in mice with obesity: Implication for olanzapine-associated metabolic changes
Xueli Zhang, Yi Zhao, Hua Shao, et al.
Psychoneuroendocrinology (2019) Vol. 108, pp. 163-171
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top